Alert detail
FDA Approval: TRYNGOLZA (OLEZARSEN SODIUM) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA218614Specialty: Multi-specialtyAdded: 6/27/2026Effective: December 19, 2024billing update
What changed
TRYNGOLZA (OLEZARSEN SODIUM) approved 2024-12-19
Who’s affected: Multi-specialty billing teams · Effective: December 19, 2024
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.